Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ACP3 | P15309 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131470 | 0.87 | HPRT1 (0.58) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL1127610 | 0.87 | CYP2C19 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL2879124 | 0.84 | IDO1 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL2845831 | 0.84 | IDO1 (0.48) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL128331 | 0.81 | CYP1A2 (0.54) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL17756341 | 0.80 | IDO1 (0.41) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL131805 | 0.79 | IDO1 (0.41) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL599659 | 0.79 | CYP2C19 (0.62) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL29490353 | 0.79 | CYP2C19 (0.62) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 | |
| SCHEMBL3047898 | 0.79 | CYP1A2 (0.62) | CYP1A2CYP2C19CYP2C9CYP2D6TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 778 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | claimed |
| US-5916905-A | ANTIARTHRITIC AGENTS; ANALGESICS; ANTIPYRETICS | G. D. SEARLE & CO. (US) | 1999-06-29 | — | — | US | claimed |
| EP-0659746-B1 | Process for the preparation of sulfonylaminocarbonyl-triazolinones | BAYER AG (DE) | 1998-05-06 | — | — | EP | claimed |
| EP-0808304-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-11-26 | — | — | EP | claimed |
| US-5686470-A | 2, 3-substituted pyridines for the treatment of inflammation | WEIER RICHARD M (US) | 1997-11-11 | — | — | US | claimed |
| US-5550244-A | Process for preparing sulphonylaminocarbonyltriazolinones | BAYER AKTIENGESELLSCHAFT (DE) | 1996-08-27 | — | — | US | claimed |
| WO-1996024584-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | claimed |
| EP-0659746-A1 | Process for the preparation of sulfonylaminocarbonyl-triazolinones | BAYER AG (DE) | 1995-06-28 | — | — | EP | claimed |
| US-4886835-A | ANTIINFLAMMATORY AGENTS | RHONE-POULENC SANTE (FR) | 1989-12-12 | — | — | US | claimed |
| US-4518596-A | Antithrombotic use of 2-(perhydro-1,4-diazino)-pyrimido (5,4,D)-pyrimidines | DR. KARL THOMAE GMBH (DE) | 1985-05-21 | — | — | US | claimed |
| EP-0055444-B1 | TRISUBSTITUTED PYRIMIDO(5,4-D)PYRIMIDINES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1985-03-20 | — | — | EP | claimed |
| EP-0023559-B1 | 2-(PERHYDRO-1,4-DIAZINO)-PYRIMIDO(5,4-D)PYRIMIDINES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1984-09-19 | — | — | EP | claimed |
| EP-4663693-A1 | METHOD FOR DECOMPOSING COMPOUND | National Institute Of Advanced Industrial Science and Technology (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-20250250229-A1 | ARYLTHIO DERIVATIVES WITH PHARMACOLOGICAL ACTIVITY | IRIDEA S.R.L. (IT) | 2025-08-07 | — | — | US | disclosed |
| WO-2024166919-A1 | METHOD FOR DECOMPOSING COMPOUND | 国立研究開発法人産業技術総合研究所 | 2024-08-15 | — | — | WO | disclosed |
| CN-115504896-B | Acrylic formate compound for LED photopolymerization, preparation method and application thereof | 湖北固润科技股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| EP-0014455-A2 | Cyclopropane(thiol)carboxylic-acid esters, processes for their preparation, pesticides containing such compounds and the use of such compounds as pesticides | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1980-08-20 | — | — | EP | disclosed |
| US-4167613-A | UNSATURATED POLYESTERS | PENNWALT CORPORATION (US) | 1979-09-11 | — | — | US | disclosed |
| US-3969414-A | Naphthylmethyl sulfonium compounds | THE DOW CHEMICAL COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3943159-A | Process for the production of telomers containing isocyanate groups | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250229-A1 | ARYLTHIO DERIVATIVES WITH PHARMACOLOGICAL ACTIVITY | FPR1, FPR3, FPR2 | CYP1A2 2006/4885CYP2C19 1384/4885CYP2C9 1572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.